The dsRNA binding site of human toll-like receptor 3

被引:171
作者
Bell, Jessica K.
Askins, Janine
Hall, Pamela R.
Davies, David R.
Segal, David M.
机构
[1] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
关键词
double-stranded RNA; innate immunity; leucine-rich repeat;
D O I
10.1073/pnas.0603245103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pathogen recognition by Toll-like receptors (TLRs) initiates innate immune responses that are essential for inhibiting pathogen dissemination and for the development of acquired immunity. The TLRs recognize pathogens with their N-terminal ectodomains (ECD), but the molecular basis for this recognition is not known. Recently we reported the x-ray structure for unliganded TLR3-ECD; however, it has proven difficult to obtain a crystal structure of TLR3 with its ligand, dsRNA. We have now located the TLR3 ligand binding site by mutational analysis. More than 50 single-residue mutations have been generated throughout the TLR3-ECD, but only two, H539E and N541A, resulted in the loss of TLR3 activation and ligand binding functions. These mutations locate the dsRNA binding site on the glycan-free, lateral surface of TLR3 toward the C terminus and suggest a model for dsRNA binding and TLR3 activation.
引用
收藏
页码:8792 / 8797
页数:6
相关论文
共 50 条
  • [1] The Toll-like receptor 3:dsRNA signaling complex
    Botos, Istvan
    Liu, Lin
    Wang, Yan
    Segal, David M.
    Davies, David R.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2009, 1789 (9-10): : 667 - 674
  • [2] Toll-like receptor 3 is necessary for dsRNA adjuvant effects
    Salaun, Bruno
    Greutert, Maude
    Romero, Pedro
    VACCINE, 2009, 27 (12) : 1841 - 1847
  • [3] Toll-like receptor 3: A link between toll-like receptor, interferon and viruses
    Matsumoto, M
    Funami, K
    Oshiumi, H
    Seya, T
    MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (03) : 147 - 154
  • [4] Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses
    Tatematsu, Megumi
    Seya, Tsukasa
    Matsumoto, Misako
    BIOCHEMICAL JOURNAL, 2014, 458 : 195 - 201
  • [5] COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?
    Dela Justina, Vanessa
    Giachini, Fernanda R.
    Priviero, Fernanda
    Webb, R. Clinton
    VASCULAR PHARMACOLOGY, 2021, 140
  • [6] Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3
    Amarante, Marla Karine
    Maeda Oda, Julie Massayo
    Vissoci Reiche, Edna Maria
    Morimoto, Helena Kaminami
    Aoki, Mateus Nobrega
    Ehara Watanabe, Maria Angelica
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (05) : 925 - 929
  • [7] Toll-Like Receptor 3 in Cardiovascular Diseases
    Zhuang, Chunying
    Chen, Riken
    Zheng, Zhenzhen
    Lu, Jianmin
    Hong, Cheng
    HEART LUNG AND CIRCULATION, 2022, 31 (07) : E93 - E109
  • [8] The effect of toll-like receptors and toll-like receptor genetics in human disease
    Garantziotis, Stavros
    Hollingsworth, John W.
    Zaas, Aimee K.
    Schwartz, David A.
    ANNUAL REVIEW OF MEDICINE, 2008, 59 : 343 - 359
  • [9] Toll-like receptor sensing of human herpesvirus infection
    West, John A.
    Gregory, Sean M.
    Damania, Blossom
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 : 122
  • [10] Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer
    Amarante, Marla Karine
    de Oliveira, Karen Brajao
    Guembarovski, Roberta Losi
    da Silva do Amaral Herrera, Ana Cristina
    Guembarovski, Alda Losi
    Sobrinho, Walter Jorge
    Voltarelli, Julio Cesar
    Ehara Watanabe, Maria Angelica
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (12) : 11087 - 11092